Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
Green tea has long been celebrated for its health benefits, largely attributed to its rich content of polyphenols, particularly Epigallocatechin Gallate (EGCG). While its systemic health benefits are widely recognized, the potential of EGCG in targeted therapeutic applications, especially in ophthalmology, is gaining significant attention. NINGBO INNO PHARMCHEM CO.,LTD. is actively involved in harnessing this natural powerhouse for advanced eye care solutions.
EGCG's key attributes for ocular health include its potent anti-inflammatory and antioxidant capabilities. Dry Eye Syndrome (DED), a complex condition characterized by tear film instability, inflammation, and ocular surface damage, can benefit greatly from these properties. EGCG can help to reduce inflammation associated with DED and combat the oxidative stress that contributes to cellular damage on the cornea and conjunctiva.
The challenge, however, lies in delivering EGCG effectively to the eye. Conventional eye drops often result in rapid dilution and clearance, meaning the therapeutic benefits of EGCG may not be fully realized. To address this, innovative drug delivery systems are being developed. One promising approach, pioneered by NINGBO INNO PHARMCHEM CO.,LTD. as a manufacturer in China, involves encapsulating EGCG within specialized hydrogels.
These hydrogels, such as the gelatin-g-poly(N-isopropylacrylamide) (GN) system, are designed for sustained release. This means that EGCG is released gradually over time, ensuring a consistent therapeutic presence on the ocular surface. This sustained delivery enhances EGCG's ability to combat inflammation and oxidative stress, leading to more effective treatment outcomes for DED. The biodegradability of these hydrogel carriers further enhances their suitability for ophthalmic use, ensuring minimal adverse effects.
Research into these advanced EGCG formulations shows promising results in preclinical studies, demonstrating improved efficacy in managing the symptoms and progression of DED. By providing a more stable and targeted delivery of EGCG, these innovations are paving the way for new, natural-based treatments for eye conditions. NINGBO INNO PHARMCHEM CO.,LTD. is committed to supplying high-quality EGCG and supporting the development of these next-generation ophthalmic therapies, bringing the power of green tea to advanced eye care.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
